IP Library Granted Patent US 7,642,062
Granted Patent B2
US 7,642,062 · App. 11/647,648 · Granted Jan 5, 2010

Compositions and methods of their use for improving the condition and appearance of skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,642,062
App. No.
11/647,648
Granted
Jan 5, 2010
Kind
B2
Abstract

The present invention relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents, or synthetic equivalents thereof, which inhibit or decrease expression of C-reactive protein expression, production or secretion, thereby reducing, inhibiting, or ameliorating dermatological signs of aging. The compositions of the invention may be topically applied to the skin, or are delivered by directed means to a site in need thereof, in an amount effective in improving the condition and aesthetic appearance of skin.

Claims (12)

1. A method of detecting CRP-associated inflammation and aging skin comprising:

a) reacting a normal skin sample with a probe; and

b) detecting the presence of the probe,

wherein the probe detects a C-reactive protein and detection of the probe indicates CRP-associated inflammation and a risk of CRP-associated progression of aging skin.

2. A method of monitoring a normal skin sample, comprising:

a) treating a normal skin sample with a test composition forming a treated skin sample;

b) reacting the treated skin sample with a probe;

c) reacting a control skin sample with a probe; and

d) comparing the control skin sample to the treated skin sample for the presence of the probe,

wherein the presence of the probe identifies the presence of C-reactive protein, thereby monitoring the treatment of a normal skin sample.

3. The method of claim 2 , wherein the probe is a nucleic acid that is specific far CRP.

4. The method of claim 2 , wherein the probe is a protein that is specific for CRP.

Assignments (3)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2007
From: DRYER, LAURENCE; TAFURI, SHERRIE R.; PTCHELINTSEV, DMITRI S.
To: AVON PRODUCTS, INC.
Reel/Frame 018921/0535 →